All Posts by
The blog series highlights how an interdisciplinary research collaboration involving Dr. Jatinder Lamba's lab led to the identification of a rare genomic phenomenon underlying CD33-negative AML.
UF Health Cancer Institute researchers aim to identify a new therapy that can improve overall ovarian cancer survival.
UF Health Cancer Institute researchers have created a novel drug that shows promise for the treatment of aggressive AML.
The findings could be used to identify women who might be at greater risk of stromal changes that could increase their breast cancer risk.
The gut microbiota drives changes to the immune system caused by chronic sleep loss, the study found.
UF researchers report evidence of differences in gene regulation based on ancestry.
For the first time, researchers have performed comprehensive genomic profiling of angiosarcoma cells.
Researchers are helping advance practical strategies to prevent cancer, improve early detection and strengthen survivorship care.
Mei Hei, Ph.D., was honored for her efforts to create a nurturing, growth-oriented homebase for her postdoctoral mentees.
Recent UF Health Cancer Institute publications.
